{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma","description":"JCO Podcast host Dr. Davide Soldato and&amp;nbsp;JCO Associate Editor Dr. Dr. Eileen M. O\u2019Reilly discuss the ASCO 2026 Simultaneous Publication paper&amp;nbsp;&quot;Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial.&quot; LINK TO FULL TRANSCRIPT ","author_name":"Journal of Clinical Oncology (JCO) Podcast","author_url":"http:\/\/sites.libsyn.com\/58526","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41396945\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/00457c\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/202234345"}